The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ehealth Inc

Nasdaq: EHTH
Last

(U.S.) $9.80

Today's change-0.28 -2.78%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.
 

Ehealth Inc

Nasdaq: EHTH
Last

(U.S.) $9.80

Today's change-0.28 -2.78%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Ehealth Inc crosses below 20-day moving average

Ehealth Inc closed sharply lower Friday, dropping (U.S.)$0.28 or 2.78% to (U.S.)$9.80 and crossing below its 20-day moving average. Shares have lost 6.58% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 4.35% during the last year.

Key company metrics

  • Open(U.S.) $10.03
  • Previous close(U.S.) $10.08
  • High(U.S.) $10.04
  • Low(U.S.) $9.65
  • Bid / Ask-- / --
  • YTD % change-1.80%
  • Volume91,482
  • Average volume (10-day)110,032
  • Average volume (1-month)117,735
  • Average volume (3-month)121,670
  • 52-week range(U.S.) $8.81 to (U.S.) $16.81
  • Beta1.25
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward16.98×
  • Forward PEG3.40×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.68
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-6.45%

Ehealth Inc has a net profit margin of -6.45%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:FinancialsIndustry:Insurance - Multiline
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue38406145
Total other revenue--------
Total revenue38406145
Gross profit38395944
Total cost of revenue0121
Total operating expense35346359
Selling / general / administrative35335658
Research & development--------
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)004--
Other operating expenses, total--------
Operating income36-2-14
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax36-2-14
Income after tax46-2-19
Income tax, total-1005
Net income46-2-19
Total adjustments to net income--------
Net income before extra. items46-2-19
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items46-2-19
Inc. avail. to common incl. extra. items46-2-19
Diluted net income46-2-19
Dilution adjustment0------
Diluted weighted average shares18181818
Diluted EPS excluding extraordinary itemsvalue per share0.200.32-0.12-1.08
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.200.320.05-1.08